Weiss Asset Management’s Envoy Medical COCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-242,639
Closed -$188K 639
2025
Q3
$188K Sell
242,639
-125,505
-34% -$170K ﹤0.01% 555
2025
Q2
$523K Sell
368,144
-19,824
-5% -$29K 0.01% 363
2025
Q1
$504K Sell
387,968
-8,686
-2% -$12.7K 0.01% 231
2024
Q4
$583K Buy
+396,654
New +$901K 0.01% 439
2024
Q2
Sell
-20,000
Closed -$78.4K 313
2024
Q1
$78.4K Hold
20,000
﹤0.01% 267
2023
Q4
$37.2K Hold
20,000
﹤0.01% 336
2023
Q3
$137K Buy
+20,000
New +$200K 0.01% 137

Other funds holding COCH

Weiss Asset Management's COCH Position: Q4 2025 in Review

Weiss Asset Management sold out of Envoy Medical (COCH) in Q4 2025, closing a stake of 242,639 shares — an estimated $188K sold.

Weiss Asset Management first reported a position in COCH in Q3 2023 and held it in 7 quarters. The position peaked at $583K in Q4 2024. 27 funds tracked by Wall St. Rank hold COCH as of Q4 2025.

  • Weiss Asset Management reported no remaining Envoy Medical position as of Q4 2025 after selling out during the quarter.
  • Weiss Asset Management sold 242,639 Envoy Medical shares in Q4 2025, an estimated $188K.
  • Weiss Asset Management first reported a position in Envoy Medical in Q3 2023 and held it in 7 quarters.
  • Weiss Asset Management's Envoy Medical position peaked at $583K in Q4 2024.
  • 27 funds tracked by Wall St. Rank held Envoy Medical as of Q4 2025.

Based on Weiss Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.